Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection

Transplantation

Volumn 61, Issue 6, 1996, Pages 862-868

  Robson, Simon C ^a   Young, Vincent K ^b   Cook, Nigel S ^c   Metternich, Rainer ^c   Kasper Konig, Walter ^b   Lesnikoski, Beth A ^a   Pierson III, Richard N ^b   Hancock, Wayne W ^a   Candinas, Daniel ^a   White, David J G ^b   Bach, Fritz H ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c Preclinical Research   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; COMPLEMENT ACTIVATION; CONTROLLED STUDY; GRAFT REJECTION; HEART OUTPUT; HEART TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; SWINE; THROMBOSIS; XENOGRAFT;

ACUTE DISEASE; ANIMALS; ANTITHROMBINS; BLOOD; DISEASE MODELS, ANIMAL; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; MYOCARDIUM; PERFUSION; SWINE; TRANSPLANTATION, HETEROLOGOUS;

EID: 9244236520     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199603270-00003     Document Type: Article

References (38)

1. Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier K, Vanhove B et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141: 5.
2. Auchincloss H, Jr. Xenografting: a review. Transplantation 1990; 4: 14.
3. Baldwin WM III, Pruitt SK, Brauer RB, Daha RM, Sanfilippo F. Complement in organ transplantation. Transplantation 1995; 59: 797.
4. Dalmasso AP, Vercellotti GM, Fischel RJ, Bolman RM, Bach FH, Platt JL. Mechanisms of complement activation in the hyperacute rejection of porcine organs transplanted into primate recipients. Am J Pathol 1992; 140: 1157.
5. Platt JL, Bach FH. Discordant xenografting: challenges and controversies. Curr Opin Immunol 1991; 3: 735.
6. Robson SC, Kopp C, Lesnikoski B. Platelets and xenograft rejection. Xeno 1994; 2: 38.
7. Blakely ML, Van Der Werf WJ, Berndt MC, et al. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
8. Robson SC, Candinas D, Hancock WW, Wrighton C, Winkler H, Bach FH. The role of endothelial cells in transplantation. Int Arch Allergy Immunol 1995; 106: 305.
9. Esmon CT. Cell mediated events that control blood coagulation and vascular injury. Annu Rev Cell Biol 1993; 9: 1.
10. Hunt BJ, Rosenberg RD. The essential role of haemostasis in hyperacute rejection. Xeno 1993; 1: 16.
11. Mann KG. Prothrombin and thrombin. In: Coleman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis. Basic principles and clinical practice. Philadelphia: Lippincott, 1994: 184.
12. Cook NS, Tapparelli C, Metternich R. Synthetic low-molecular weight thrombin inhibitors. Can J Physiol Pharmacol 1994; 72 (suppl 1): 151.
13. Tapparelli C, Metternich R, Ehrhardt C, Cook NS. Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile. TiPS 1993; 14: 366.
14. Hunt BJ, Dunning JJ, Segal H, Parratt R, White DJG, Wallwork J. Pig-to-human xenograft rejection: is haemostatic activation dependent on the presence of anti-pig antibodies or complement? Transplant Proc 1994; 26: 1156.
15. Perkins SJ, Smith KF. Identity of the putative serine-proteinase fold in proteins of the complement system with nine relevant crystal structures. Biomed J 993; 295: 109.
16. Forty J, White DG, Wallwork J. A technique for perfusion of an isolated working heart to investigate hyperacute discordant xenograft rejection. J Thorac Cardiovasc Surg 1993; 106: 308.
17. Suckfull MM, Pieske O, Mudsam M, Babic R, Hammer C. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. Transplantation 1994; 57: 262.
18. Gautreau C, Cardoso J, Jeyaraj P, et al. Relationship between human anti-A, anti-B alloantibodies and anti-pig xenoantibodies. Transplant Proc 1993; 25: 389.
19. Spannagl M, Bichler J, Birg A, Lill H, Schramm W. Development of a chromogenic assay for the determination of hirudin in plasma. Blood Coagul Fibrinolysis 1991; 2: 121.
20. Bauer KA, Weitz JI. Laboratory markers of coagulation and fibrinolysis. In: Coleman RW, Hirsh J, Marder VJ, Salzman EW, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: Lippincott, 1994: 1197.
21. Preissner KT. Anticoagulant potential of endothelial cell membrane components. Haemostasia 1988; 18: 271.
22. Dalmasso AP. The complement system in xenotransplantation. Immunopharmacology 1992; 24: 149.
23. Platt JL, Fischel RJ, Matas AJ, Reif SA, Bolman RM, Bach FH. Immunopathology of hyperacute rejection in a swine to primate model. Transplantation 1991; 52: 214.
24. Salzman EW, Rosenberg RD, Smith MH, Lindon JN, Favreau L. Effect of heparin and heparin fractions on platelet aggregation. J Clin Invest 1980; 65: 64.
25. Rose AG, Cooper DKC, Human PA, Reichenspurner H, Reichart B. Histopathology of hyperacute rejection of the heart: Experimental and clinical observations in allografts and xenografts. J Heart Lung Transplantation 1991; 10: 223.
26. Cooper DKC, Ye Y, Rolf JLL, Zuhdi N. The pig as potential organ donor for man. In: Cooper DKC, Kemp E, Reemtsma K, White DJG, eds. Xeno-transplantation: the transplantation of organs and tissues between species. Berlin: Springer 1991: 481.
27. Calne RY. Organ transplantation between widely disparate species. Transplant Proc 1970; 2: 550.
28. Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothorac Surg 1993; 7: 563.
29. Hebert CA, Luscinskas FW, Kiely JM, et al. Endothelial and leucocyte forms of IL-8: conversion by thrombin and interactions with leukocytes. J Immunol 1990; 145: 3033.
30. Mackman N. Protease inhibitors block lipopolysaccharide induction of tissue factor gene expression in human monocytic cells by preventing activation of c-rel/p65 heterodimers. J Biol Chem 1994; 269: 26363.
31. Henkel T, Machleidt T, Alkalay I, Kronke M, Benneriah T, Baeuerle PA. Rapid proteolysis of IκBa is necessary for activation of transcription factor nf-kappa-b. Nature 1993; 365: 182.
32. Prisco D. Markers of increased thrombin generation. Ric Clin Lab 1990; 20: 217.
33. Carson SD, Johnson DR. Consecutive enzyme cascades: complement activation at the cell surface triggers increased tissue factor activity. Blood 1990; 76: 361.
34. Cook NS, Kottirsch G, Zerwes HG. Platelet glycoprotein IIb/IIIa antagonists: drugs of the future 1994; 19: 135.
35. Pareti FI, Mazzucato M, Bottini E, Mannucci PM. Interaction of porcine von Willebrand factor with the platelet glycoproteins Ib and IIb/IIIa complex. Br J Haematol 1992; 82: 81.
36. Rosengard AM, Cary NRB, Langford GA, Tucker AW, Wallwork J, White DJG. Tissue expression of human complement inhibitor, decay accelerating factor (DAF), in transgenic pigs - a potential approach for preventing xenograft rejection. Transplantation (in press).
37. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine to primate cardiac xenografts from humoral injury. Nature Med 1995; 1: 423.
38. Pruitt SK, Kirk DA, Bollinger RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994; 57: 363.